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ABSTRACT 
Objective: The main objective of this study is to investigate the antioxidant and nephroprotective efficacy of moringa oleifera seed extract (MOSE) 
against cisplatin which induced acute renal injury.  
Methods: Forty male Wister rats were equally segregated into 4 groups (10 rats per group): group I (0.5 ml of sterile saline orally), group II 
(200 mg MOSE/kg b. wt orally for 10 consecutive days), group III (7.5 mg cisplatin/kg b. wt/intraperitonially as a single dose on the 5th day 
of the experiment) and group IV (200 mg moringa oleifera seed extract (MOSE)/kg orally for 10 d followed by 7.5 mg cisplatin/kg body 
weight/intraperitonially once as a single dose on the 5th day of the experiment. Serum biochemical analysis of renal biomarkers (urea, uric 
acid, and creatinine), oxidative stress markers (malondialdehyde [MDA]), a crucial antioxidant enzyme (catalase) and the expression of 
renal activity interleukin (IL)-6, (IL)-10 and Tumer necrotic factor (TNF-α) mRNA were determined. Histopathological examination of renal 
tissue was done. 
Results: Cisplatin induced renal damage, increased renal biomarkers (urea, creatinine and uric acid)(375.87±1.65, 5.238±0.25, 4.47±0.25). Tissue 
concentrations of malondialdehyde, IL-6 and TNF-α.(387.56±0.97, 2.188±0.20, 3.06±0.27)compared to control group(140.58±1.25,0.938±0.017, 
1.24±0.17), (163.99±1.34, 1.008±0.05, 0.982±0.026) Moreover, cisplatin induced significantly down-regulation of anti-inflammatory (IL-10) and 
catalase (0.780±0.47, 1.62±0.06) compared to control one (1.010±0.02, 3.12±0.11),. The histopathological examination showed renal tissue damage 
and degeneration of tubules in the cortical portion in cisplatin group. However, interestingly concurrent adminsteration of the MOSE with cisplatin 
can alleviated the renal damage, oxidative stress and renal toxicity caused by cisplatin.  
Conclusion: These results suggest that the antioxidant and the anti-inflammatory effects of MOSE alleviate the cisplatin-induced nephrotoxicity. 
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INTRODUCTION  
Cisplatin is an important anticancer drug. It kills cancer cells via 
various mode of actions varying from oxidative stress, reactive 
oxygen species production, lipid peroxidation and activation of 
pro-inflammatory cytokines. Knowing these mechanisms of action 
may be an effective way in the strategy of prevention of its side 
effects on normal cells [1]. Despite considering it as a useful and 
effective drug in the treatment of many solid tumors, it has many 
hazard effects including hepatotoxicity, sever kidney injury, 
ototoxicity and cardiac toxicity [2]. The cisplatin-induced kidney 
injury remains a serious complication that still lacks effective ways 
of prevention.  
Nutraceuticals from medicinal plants are considered the most 
desired adjunctive therapy with chemotherapeutic drugs in the 
treatment of most cancers. MOSE, is one of these effective plants. 
Moringa oleifera belognes to family Moringaceae is an effective 
remedy for malnutrition. Moringa is rich in nutrion owing to the 
presence of essential phytochemicals present in its leaves, ponds 
and seeds [3]. Moringa leaf extract is rich in antioxidants, 
polyphenols, oxidase and catalase. Accordingly, it exhibited a great 
pharmacological and nutritional benefits including protection 
against hepatorenal, cardiovascular and neurological disorders. It 
also has anti-inflammatory, antipyretic, anticancer and antioxidant 
activities [4, 5]. 
The pharmacological adjunctive usage of moringa oleifera to 
alleviate the cisplatin induced nephrotoxicity was the main objective 
of this study. 
MATERIALS AND METHODS  
Plant and chemicals 
Moringa oleifera 
The seeds of Moringa oleifera were purchased from Haraz Company 
of agricultural seeds, spices and medicinal plants, Cairo, 
Governorate, Egypt. The seeds were collected in March 2019.  
Preparation of extract of Moringa oleifera seeds 
Moringa oleifera seeds were flowed back in tap water and then with 
bi-distilled water, dried at room temperature and coarsely minced 
using a pestle and mortar. Extracts were prepared by macerating a 
weighed amount of the minced parts (200 g) in volume (2 Liters) of 
water/organic solvent (bi-distilled water: absolute ethanol, 70:30, and 
v/v). Maceration continued for 72 h in freezing with intermittent 
shaking. The extract was then strained through muslin mesh, filtered 
through what man paper (1). The obtained filtrate was then 
concentrated using a shaking water bath at 70 °C in a wide-mouthed 
containers and brown semisolid extract was obtained. It was then 
weighed (25 g). It re-dissolving in measured amount of iso saline 
(0.85%, w/v). The extract was stored in airtight container in freezing 
below 10 °C. a stock solution was diluted which were used for the 
antioxidant activity testing. For in vivo studies [6]. It was used as a 
dose of (200 mg/kg b. wt MOSE orally for 10 consecutive days) [7].  
Chemicals, reagents and kits 
Cisplatin was used under the trade name of (Cytoplatin 10 aquas) 
imported by star INT company and manufacture by CIPLA LTD. Each 
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20 ml vial contain 10 mg cisplatin. It was used at dose of 7.5 mg/kg 
b. wt at the 5th day of the experiment [8].  
Kits 
Kits for estimating Urea, creatinine and uric acid were supplied by 
Centronic GmbH Company Germany by chem7, Kits for estimating of 
oxidative stree marker Malondialdehyde (MDA), catalase (CAT) in 
kidney homogenate were purchased from BioDiagnostic Company, 
Cairo, Egypt by spectro nanodrop. Genes expression was made using 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, CA, 
USA), and SYBR green master (Applied Biosystems, CA, USA) 
Animals  
About forty healthy Wister male rats weighting 200-250 gm were 
obtained from the animal house of faculty of veterinary medicine, 
Benha University. They were fed on standard rodent diet and clean 
water ad libitum. Rats were left for two weeks for acclimatization 
before the beginning of the experiment.  
Experimental design and treatment protocol 
Forty male Wistar rats were divided randomly into 4 groups (10 
animals per group). Group I (control group) they were administered 
0.5 ml of saline orally for 10 consecutive days. Group II (moringa 
group) they were administered 200 mg/kg b. wt Moringa oleifera 
seed extract (MOSE) orally for 10 consecutive days. Group III 
(cisplatin group) they were administered cisplatin at dose of 7.5 
mg/kg body weight/intraperitonially as single dose on the 5th day of 
experiment. Group IV (Cis+Moringa), they were administered 
Moringa oleifera seed extract MOSE at dose of 200 mg/kg orally for 
10 d and single dose of cisplatin at dose of 7.5 mg/kg body 
weight/intraperitonially on the 5th day of experiment one hour prior 
to dose of MOSE. 
Blood sampling 
At the end of the experiment blood samples were taken from each 
rat for biochemical analysis from the median canthus of the eye. 
Blood sample was collected without anticoagulant for separation of 
clear serum for biochemical analysis. These serum samples were 
used for biochemical analysis of (creatinine, urea and Uric acid).  
Tissue samples  
At the end of the experiment all rats were scarified, and tissue 
samples were taken from kidney for both biochemical study of 
oxidative stress markers (MDA, CAT, IL-10, IL-6 and TNF-α) and for 
histopathological examination.  
Assay methods 
Serum biochemical analysis 
Serum creatinine was measured spectrophotometrically according 
to [9] using specific kits from Diamond Company. Serum urea 
concentration was determined according to [10] by kits from 
Diamond Company. 
Evaluation of renal oxidative stress markers 
Both kidneys were taken immediately after scarification, washed in 
physiological saline. One kidney was preserved at-80c until preparation 
of tissue homogenate which used for assessment of (MDA and CAT) 
levels calorimetrically. According to [11, 12] respectively.  
Gene’s expression by real time PCR 
Total RNA was isolated from kidney tissue using the Total RNA 
Isolation System (Promega Co., Madison, WI, USA) according to the 
manufacturer's protocol. Briefly, RNA was extracted and re-
suspended in 50 μL RNase free water, then stored at −80  °C. The 
total RNA concentration was determined spectrophotometrically 
(SPECTRO star Nano, BMG Labtech Co., Ortenberg, Germany) and 
then 1 μg of RNA was used for cDNA synthesis using the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, CA, 
USA). The condition was achieved in line with the kit of cDNA 
reverse transcription as follow; step I (10 min/25 °C), step II (120 
min/37 °C), step III (5 min/85 °C) and step IV (∞~ at 4 °C), then, 1 
μg of the obtained cDNA with the SYBR green master mix were used 
in a total of 20 μl reaction volume 7 μl of nuclease-free water, 10 μl 
of master mix, 1 μl of forward primer, 1 μl of reverse primer, and 1 
μl of DNA template) for HSP70 and β-actin gene amplification using 
the following primers:  
IL 6 Forward GACTTCCAGCCAGTTGCCTTCTTG, IL 6 Reverse 
TGGTCTGTTGTGGGTGGTATCCTC, IL 10 Forward TGCCAAGC 
CTTGTCAGAAATGATCAAG, IL 10 Reverse TGCCAAGCCTTGTCAG 
AAATGATCAAG, TNF-α Forward AAATGGGCTCCCTCTCATCAGTTC, 
TNF-α Reverse TCCGCTTGGTGGTTTGCTACGAC, GAPDH 5′-AACTCCCA 
TTCCTCCACCTT-3′ forward, 5′-GAGGGCCTCTCTCTTGCTCT-3′ reverse. 
The genes were amplified then the expression levels were analyzed 
using a real-time PCR (7500 Fast Real-Time PCR System, Applied 
Biosystems, CA). The cycling condition was justified first the initial 
activation (3 min/95 °C), denaturation (3 s/95 °C), annealing/ 
extension (30 s/60 °C), and the number of cycles were 40 according 
to [13]. All gene expression level was normalized against the GAPDH 
gene. 
Histopathology examination 
Autopsy from the kidney of rats in different groups were taken and 
fixed in 10% formol saline for twenty-four hours. Washing by tap 
water then serial dilutions of alcohol (methyl, ethyl and absolute 
ethyl) were used for dehydration. Specimens were cleared in xylene 
and embedded in paraffin at 56 degree in hot air oven for twenty-
four hours. Paraffin bees wax tissue blocks were prepared for 
sectioning at 4 microns thickness by sledge microtome. The tissue 
sections were taken on glass slides, deparaffinized, stained by 
hematoxylin and eosin stain for examination through the light 
electric microscope [14]. 
Statistical analysis 
The results were done as mean±SE of the experimental groups using 
(one-way ANOVA) followed by Duncan’s multiple range test. All 
analysis was performed by Statistical Package for Social science 
Software (SPSS (16) software (SPSS Inc., Chicago, USA). 
RESULTS 
There was no mortality observed in any group of the experiment 
during the period of the experiment. Regarding to the biochemical 
renal parameters (urea, creatinine and uric acid) there was 
significant increase (p<0.001) in the urea (375.87±1.65), creatinine 
(5.23±0.25) and uric acid (4.47±0.25) levels in the cisplatin group 
when compared to control group, moringa group and Cis+Moringa 
group table 1. 
Analysis of the lipid peroxidation parameter MDA, there was 
significant elevation in MDA level (p<0.001) in the cisplatin group 
(387.5±1.49) when compared to control group (163.99±1.3), 
moringa group (213.34±1.3) and Cis+Moringa group (180.68±0.97) 
table 2. 
The catalase level showed significant decrease (p<0.001) in cisplatin 
group (1.62±0.06) when compared to control group (3.12±0.11), 
moringa group (3.56±0.17) and Cis+Moringa group (2.15±0.08). 
The IL-6 gene expression level was significantly higher (p<0.001) in 
the cisplatin group (2.19±0.20) than in the control, Cis+Moringa and 
Moringa groups (1.01±0.05,1.40±0.02, and 1.34±0.05 respectively). 
The gene expression level of IL-10 was down regulated in the kidney 
tissue of the Cisplatin group rats (0.78±0.473) compared with other 
groups and TNF-α upregulated in cisplatin groups (3.0620±0.277) 
compared with other groups. All these data illustrated in table 3. 
Histopathological findings 
Regarding to the histopathological examination of the renal tissue, 
the cisplatin group showed focal infiltration of the inflammatory 
cells in between the degenerated tubule in the cortical portion fig. 
1(C) with congestion in the blood vessels and glomeruli as well as 
degeneration and desquamation in the tubular lining epithelium fig. 
1(D and E). There was no histopathological alteration and the 
glomeruli and tubules at the cortex appeared with normal 
histological structure in control group fig. 1(A) and in moringa group 
Elsayed et al. 
Int J Pharm Pharm Sci, Vol 13, Issue 5, 78-82 
80 
fig. 1(B). The cortex showed normal histological structure in 
cisplatin+moringa group fig. 1(F), while the corticomedullary 
portion showed degeneration and desquamation in the lining 
epithelium in fig. 1(G). 
 
Table 1: Effect of oral administration of MOSE at 200 mg/kg body weight for successive 10 d on renal biomarker (Urea, creatinine, uric 
acid) on cisplatin (7.5 mg/kg b. wt.) intoxicated rats.(n=10) 
Groups/parameters Urea (mg/dl)  Creatinine (mg/dl) Uric acid (mg/dl) 
Control 140.58±1.25c 0.938±0.017c 1.246±0.17b 
Moringa 139.6±1.58c 0.946±0.022c 1.540±0.22b 
Cisplatin 375.87±1.65a 5.238±0.25a 4.47±0.25b 
Cis.+Moringa 192.30±1.51b 2.276±0.22b 2.377±0.22b 















Fig. 1: Histopathological examination of rat kidney sections of different experimental groups stained with (HandE X40). There was no 
histopathological alteration and the normal histological structure of the glomeruli and tubules at the cortex in control (A) and moringa 
group (B). The cortical portion showed focal inflammatory cells infiltration in between the degenerated tubule. m: Focal inflammatory 
cell infiltration g: glomeruli d: degenerated tubules at cisplatin group (C). Congestion in the blood vessels and glomeruli as well as 
degeneration and desquamation in the tubular lining epithelium in cisplatin group (Dand E). bv: congested blood vessels, g: glomeruli. 
Cortex showed normal histological structure in cisplatin+moringa group (F), while the corticomedullary portion showed degeneration 
and desquamation in the lining epithelium in cisplatin+moringa group (G) 
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Table 2: Effect of oral administration of MOSE at 200 mg/kg body weight for successive 10 d on renal oxidative stress biomarker (MDA, 
CAT) on cisplatin (7.5 mg/kg b. wt.) intoxicated rats.(n=10) 
Groups/parameters MDA (nmol/gm)   CAT (U/gm) 
Control 163.99±1.34d  3.12±0.11b 
Moringa 213.34±1.33b  3.56±0.17a 
Cisplatin 387.50±1.49a 1.62±0.06d 
Cis.+Moringa 180.68±0.97c 2.15±0.08c 
Data are represented as (mean of 10rats±SE). Mean values with different superscriped letters in the same column are significantly different  
 
Table 3: Effect of oral administration of MOSE at 200 mg/kg body weight for successive 10 d on renal IL-6, IL-10 and TNF-α on cisplatin 
(7.5 mg/kg b. wt.) intoxicated rats.(n=10) 
Groups/parameters IL-6 IL-10 TNF-α 
Control 1.0080±0.05c 1.010±0.02b 0.9820±0.026b 
Moringa 1.3420±0.05b 1.1520±0.04b 1.0180±0.27b 
Cisplatin 2.1886±0.20a 0.780±0.47c 3.0620±0.277a 
Cis.+Moringa 1.4020±0.02b 1.832±0.13a 1.5880±0.19b 
Data are represented as (mean of 10rats±S. E). Mean values with different superscripted letters in the same column are significantly different 
 
DISCUSSION 
Cisplatin is an important anti-neoplastic agent. It is a useful drug in 
the treating of many types of solid tumors. Nephrotoxicity is the 
main adverse side effect of cisplatin. This experiment was done to 
determine the antioxidant and nephroprotective efficacy of MOSE 
against cisplatin induced acute renal damage. Moringa oleifera seed 
extract MOSE has antioxidant properties.  
Our results showed a state of oxidative stress-mediated renal injury 
after treatment of rats with a single i. p. dose of cisplatin as it is 
indicated by significant elevation in serum urea, uric acid, creatinine 
and renal tissue levels of MDA with significant reduction in renal 
tissue level of catalase. This state of renal injury was confirmed with 
histopathological examination of kidney tissue that reviled focal 
inflammatory cells infiltration in between the degenerated tubules 
in the cortical portion with degeneration and desquamation in the 
lining epithelium fig. 1(c). This state of renal injury may be because 
of the oxidative stress and inflammatory effects of cisplatin. This 
injury may be because of the liberated free radicals cause membrane 
lipid peroxidation and denaturation of both DNA and proteins. This 
damage leads to enzymatic inactivation and mitochondrial 
dysfunction that enhance ROS production via the disruption of the 
respiratory chain [15]. Catalase enzyme is a thiol-containing enzyme. 
It is an important enzyme for the neutralization of ROS [16, 17]. 
The increased serum levels of renal biomarkers urea, creatinine, and 
uric acid after cisplatin administration in a single i. p. dose coincided 
with [18] who recorded that cisplatin enhances glomerular filtration 
membrane damage through oxidative stress, inflammation, and 
apoptosis. This damage resulting in low glomerular filtration rate 
and loss of normal membrane permeability.  
In our study MOSE administration reduced the oxidative stress state 
through significant reduction in serum creatinine, urea and renal 
MDA level with significant elevation in the renal catalase level. Our 
results matched with [19] who said that MOSE protected the renal 
tissue by restoring the kidney integrity and regenerative capacity 
and also by decreasing the elevated urea and creatinine in response 
to exposure to cisplatin. The possible protective effect of Moringa 
oleifera seed extract (MOSE) on these markers may be a result of the 
antioxidant action of oleic and linoleic acid, which are both 
constituents of the moringa plant. In this regard [20]. Reported that 
any natural compound with antioxidant effects may help in 
preserving a healthy state when continuously taken naturally or 
therapeutically. As agreed with [21] who reported that moringa 
extract effectively inhibit CCL4induced tissue damage due to 
presence of various antioxidant bioactive compound.  
Moringa oleifera seed extract (MOSE) is a highly enriched compound 
with flavonoids and phenolic constituents, which have a 
cytoprotective and antioxidant effects on the renal tissue, [22-24]. 
Antioxidant compounds of plant are able to perform their safety 
roles in living organisms by stopping free radicals production or by 
counterbalancing them [25, 26]. 
The antioxidant activity of Moringa oleifera seed extract (MOSE) is 
thought to be the key factor as a reno protective agent. 
In the present study the cisplatin increased the expression levels of 
IL-6 and TNF-α that is in agreement with [27] were found Many 
cytokines (e. g. TNF-α, IL,-1 and IL-6) are upregulated in the renal 
tissues inflammatory conditions caused by cisplatin. While the levels 
of IL6 and TNFα restored to normal levels in the Moringa with 
cisplatin group because of Moringa has antibiotic, antitrypanosomal, 
hypotensive, antispasmodic, antiulcer, anti-inflammatory, 
hypocholesterolemic and hypoglycemic activities [28]. Cisplatin 
induced TNF-α is highly dependent upon the Reactive oxygen 
species (ROS) production, NF-κB and p38 MAPK activation. 
However, the activation of TNF-α and IL are involved in many signal 
transduction mechanisms, involving the NF-κB and AP-1 pathways. 
Exactly, the stress-activated group of MAPKs (JNK and p38) is 
strongly activated by TNF-α and IL [29]. 
Antioxidant property of Moringa which could be possibly the 
primary mechanism of protection against cisplatin toxicity due to 
Moringa contains antioxidant compounds that was confirmed in this 
study, such as vitamin A, which quench ROS, combined with metal 
ions and regenerate membrane-bound antioxidants. These findings 
are matched with previous reports of [30]. 
Several studies have expressed that cytokines such as IL-10 
counterbalance or inhibit the increase in other pro-inflammatory 
cytokine levels in order to protect tissue against injury in various 
pathophysiological conditions. [31]. IL-10 exerts anti-inflammatory 
and anticytotoxic effect in kidney injury accompanied with lupus 
nephritis, immune complex glomerulonephritis and ischemic or 
cisplatin-induced nephrotoxicity [32]. The findings of the other 
study stated the animals receiving cisplatin the levels of IL-10 
decreased [33]. While IL-10 gene expression regained to normal 
level with administration of Moringa with cisplatin to normal level 
due to moringa decrease inflammation and oxidative stress caused 
by cisplatin corresponding to the findings have revealed that 
Moringa prevent oxidative stress-mediated toxicity in the brain 
tissue, testis, liver, and kidney of rats [34-36]. Moringa leaves 
extracts have a powerful antioxidant action against free radicals, 
prevent oxidative damage to major biomolecules and provide 
substantial protection against oxidative damage [37-38]. 
CONCLUSION 
The results of this study show a possible explanation for the protective 
effects of Moringa oleifera seed extract (MOSE) against cisplatin 
induced nephrotoxicity. Concurrent administration leads to significant 
decreased renal biomarkers (urea, creatinine and uric acid) 
(192.30±1.51, 2.276±0.22, 2.377±0.22), tissue concentrations of 
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malondialdehyde, IL-6 and TNF-α. (180.68±0.97, 1.40±0.02, 
1.58±0.19) compared to cisplatin group (375.87±1.65, 5.238±0.25, 
4.47±0.25), (387.50±1.49, 2.188±0.20, 3.06±0.27) Moreover, induced 
significantly up-regulation of anti-inflammatory (IL-10) and catalase 
(1.832±0.13, 2.15±0.08) compared to cisplatin group (0.780±0.47, 
1.62±0.06). All this enhanced with a great protective effect of MOSE on 
renal tissue represented in no histopathological alteration. It may be 
due to its antioxidant scavenging properties and down regulation of 
the proinflammatory cytokine like (IL-6). These ensures the possible 
applied values of MOSE in preventing nephrotoxicity. 
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